SGEN - Seattle Genetics, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue482,250418,147336,802
Cost of Revenue54,11842,31737,440
Gross Profit428,132375,830299,362
Operating Expenses
Research Development456,700379,308294,529
Selling General and Administrative167,233139,247125,783
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-195,801-142,725-120,950
Income from Continuing Operations
Total Other Income/Expenses Net36,9142,614464
Earnings Before Interest and Taxes-158,887-140,111-120,486
Interest Expense---
Income Before Tax-158,887-140,111-120,486
Income Tax Expense-33,357--
Minority Interest---
Net Income From Continuing Ops-125,530-140,111-120,486
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-125,530-140,111-120,486
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-125,530-140,111-120,486